Facilitators and barriers to medication adherence among stroke survivors in India

被引:12
作者
Shani, S. D. [1 ]
Sylaja, P. N. [2 ]
Sarma, P. Sankara [1 ]
Kutty, V. Raman [3 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Achutha Menon Ctr Hlth Sci Studies AMCHSS, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Dept Neurol, Thiruvananthapuram 695011, Kerala, India
[3] Amala Canc Res Ctr, Trichur 680555, India
关键词
Medication adherence; Risk factor control; Stroke survivors; Life style; India; SECONDARY PREVENTION; ISCHEMIC-STROKE; RISK;
D O I
10.1016/j.jocn.2021.03.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strict compliance with medication and life style modification are integral to secondary stroke prevention. This study was undertaken to find out medication adherence among stroke survivors and factors associated with it. Cross sectional survey among stroke survivors was conducted. Interview based self-reported medication adherence was defined as consumption at least >80% of their medications for last two weeks, based on last prescription. Structured interview using pretested interview schedule was done to collect other data. Sequential step wise logistic regression analysis was done to find out the facilitators and barriers to medication adherence. Two hundred and forty stroke survivors (mean age 58.64 +/- 10.96 years; 25.4% females) with a mean post-stroke period of 6.65 +/- 3.36 months were participated. Overall medication adherence was 43.8% (n = 105). Medication adherence was 34.3% (n = 134), 52.6% (n = 190) and 56.7% (n = 224) for antidiabetics, antihypertensives and statins respectively and was associated with risk factor control (Diabetes: Odds Ratio (OR) = 4.85; 95% Confidence Interval (CI) 2.12-11.08, Hypertension: OR = 3.42; 95% CI 1.83-6.4, Dyslipidaemia: OR = 3.88; 95% CI 1.96-4.04). Having daily routine (OR = 2.82; 95% CI 1.52-5.25), perceived need of medication (OR = 2.33; 95% CI 1.04-5.2) and perceived poor state of health (OR = 2.65; 95% CI 1.30-5.40) were facilitators. Memory issues (OR = 0.34; 95% CI 0.16-0.71), side effects (OR = 0.24; 95% CI 0.11-0.42) and financial constraints (OR = 0.46; 95% CI 0.24-0.91) were barriers to medication adherence. Establishing daily routines, periodic reminders, financial supports to buy medicines and patient education can enhance medication adherence to prevent future strokes. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
[21]   A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider [J].
Hamrahian, Seyed Mehrdad ;
Maarouf, Omar H. ;
Fulop, Tibor .
PATIENT PREFERENCE AND ADHERENCE, 2022, 16 :2749-2757
[22]   Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence [J].
Sherwin, LeeAnne B. ;
Ross, Diana ;
Matteson-Kome, Michelle ;
Bechtold, Matthew ;
Deroche, Chelsea ;
Wakefield, Bonnie .
JOURNAL OF PATIENT EXPERIENCE, 2020, 7 (05) :726-733
[23]   Medication adherence after pediatric allogeneic stem cell transplantation: Barriers and facilitators [J].
Hoegy, Delphine ;
Bleyzac, Nathalie ;
Rochet, Chrystele ;
De Freminville, Humbert ;
Renard, Cecile ;
Kebaili, Kamila ;
Bertrand, Yves ;
Dussart, Claude ;
Janoly-Dumenil, Audrey .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2019, 38 :1-7
[24]   Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana [J].
Ankrah, Daniel N. A. ;
Koster, Ellen S. ;
Mantel-Teeuwisse, Aukje K. ;
Arhinful, Daniel K. ;
Agyepong, Irene A. ;
Lartey, Margaret .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :329-337
[25]   Key Barriers to Medication Adherence in Survivors of Strokes and Transient Ischemic Attacks [J].
Kronish, Ian M. ;
Diefenbach, Michael A. ;
Edmondson, Donald E. ;
Phillips, L. Alison ;
Fei, Kezhen ;
Horowitz, Carol R. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (05) :675-682
[26]   Key Barriers to Medication Adherence in Survivors of Strokes and Transient Ischemic Attacks [J].
Ian M. Kronish ;
Michael A. Diefenbach ;
Donald E. Edmondson ;
L. Alison Phillips ;
Kezhen Fei ;
Carol R. Horowitz .
Journal of General Internal Medicine, 2013, 28 :675-682
[27]   Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups [J].
Dworkin, Mark S. ;
Douglas, G. W. ;
Rani, G. P. Sabitha ;
Chakraborty, Apurba .
INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (03) :186-195
[28]   Factors Influencing 1-Year Medication Adherence of Korean Ischemic Stroke Survivors [J].
Gye-Gyoung Kim ;
Duck-Hee Chae ;
Man-Seok Park ;
Sung-Hee Yoo .
International Journal of Behavioral Medicine, 2020, 27 :225-234
[29]   A Systematic Review of Randomized Controlled Trials of Medication Adherence Interventions in Adult Stroke Survivors [J].
Wessol, Jennifer L. ;
Russell, Cynthia L. ;
Cheng, An-Lin .
JOURNAL OF NEUROSCIENCE NURSING, 2017, 49 (02) :120-133
[30]   Do facilitators and barriers to community ambulation differ among stroke survivors in low resource settings? A cross-sectional study in Nigeria [J].
Odetunde, Marufat O. ;
Olaoye, Olumide A. ;
Ogwogho, Halimat O. ;
Onigbinde, Ayodele Teslim .
TOPICS IN STROKE REHABILITATION, 2025, 32 (04) :349-361